Guidelines and Recommendations
This collection is a one-stop shop for guidelines or recommendations developed by CDC, CDC working in collaboration with other organizations or agencies, or by CDC federal advisory committees. These documents contain statements that include recommendations, strategies, and/or information that assists decision makers (such as healthcare providers, federal, state or private agencies, employers, public health officials, or the public) in choosing between alternative courses of action in specific situations. Ultimately, these documents are focused on providing actionable steps to address a specific issue of importance to public health.
The topical areas covered include surveillance, investigation, diagnosis, treatment, intervention, prevention, control, and public health preparedness among others for several diseases and conditions.
Select all docs (Max 200)
Narrow Results:
More
More
More
More
More
More
More
More
More
Diseases and Conditions
Public Health
Status
- Current 474
- Partially Superseded 1
- Retired 32
- Superseded 277
- Unknown 1
Federal Advisory Committee
More
Publish Year
- 2021 3
- 2020 3
- 2019 3
- 2018 17
- 2017 13
- 2016 20
- 2015 14
- 2014 24
- 2013 34
- 2012 20
- 2011 44
- 2010 32
- 2009 34
- 2008 33
- 2007 22
- 2006 25
- 2005 23
- 2004 17
- 2003 30
- 2002 23
- 2001 30
- 2000 14
- 1999 16
- 1998 17
- 1997 14
- 1996 13
- 1995 12
- 1994 13
- 1993 17
- 1992 12
- 1991 14
- 1990 12
- 1989 16
- 1988 16
- 1987 6
- 1986 1
- 1985 3
- 1984 3
- 1983 6
- 1981 4
- 1980 1
- 1979 4
- 1978 28
- 1977 22
- 1976 29
- 1975 8
- 1974 9
- 1973 7
- 1972 7
Genre
- Abbreviations 1
- Bibliography 3
- Charts, Diagrams, Etc. 1
- Classification 1
- Conference Publications 4
- Fact Sheet 2
- Guidance 40
- Guideline 70
- Handbooks 3
- Legislation 1
- Map 1
- Practice Guideline 157
- Review 1
- Standards 125
- Statistics 5
- Terminology 1
Document Type
- Book 56
- Journal Article 179
- Journal Issue 245
- Pamphlet (or booklet) 82
- Poster 1
- Press Release 1
- Report 168
- Table 1
- Transcript 1
- Webpage 5
Subject
- Acquired Immunodeficiency Syndrome 13
- administration & dosage 33
- Adolescent 74
- Adult 87
- adverse effects 30
- Aged 33
- Animals 33
- Anthrax 14
- Anti-HIV Agents 10
- Anti-HIV Agents/therapeutic use 11
- Antibiotic Prophylaxis 15
- Antiviral Agents 23
- Bacterial Vaccines 11
- Bioterrorism 15
- Cardiovascular Diseases 10
- Child 92
- Child, Preschool 74
- Communicable Disease Control 19
- Communicable Disease Control/standards 10
- Contact Tracing 11
- contraindications 13
- Cost-Benefit Analysis 11
- Counseling 14
- Cross Infection 18
- diagnosis 13
- Diphtheria-Tetanus-acellular Pertussis Vaccines 10
- Diphtheria-Tetanus-Pertussis Vaccine 12
- Disaster Planning 16
- Disease Outbreaks 36
- Disease Outbreaks/prevention & control 27
- drug therapy 15
- Environmental Exposure 85
- Environmental Health 14
- epidemiology 28
- Female 62
- Guidelines as Topic 11
- Health Education 10
- Health Personnel 17
- Health Promotion 13
- Hepatitis B 10
- Hepatitis B Vaccines 12
- HIV Infections 47
- HIV Infections/prevention & control 15
- Humans 225
- Immunization 16
- Immunization, Secondary 20
- Immunization Programs 10
- Immunization Schedule 102
- Industrial safety 10
- Infant 83
- Infant, Newborn 30
- Infection Control 34
- Influenza, Human 29
- Influenza, Human/prevention & control 13
- Influenza A virus 14
- Influenza B virus 18
- Influenza Vaccines 33
- Influenza Vaccines/administration & dosage 10
- Licensure 12
- Male 39
- Mass Screening 21
- Meningococcal Infections 11
- Meningococcal Vaccines 17
- methods 12
- Middle Aged 42
- Mycobacterium tuberculosis 12
- Occupational Diseases 21
- Occupational Diseases/prevention & control 73
- Occupational Exposure 47
- Occupational Health 11
- Patient Education as Topic 11
- Pneumococcal Vaccines 11
- Population Surveillance 20
- Practice Guidelines as Topic 17
- Pregnancy 57
- Pregnancy Complications, Infectious 25
- prevention & control 82
- Public Health 14
- Public Health Practice 18
- Rabies 22
- Rabies Vaccines 20
- Randomized Controlled Trials as Topic 11
- Risk 12
- Risk Assessment 17
- Risk Factors 41
- Sexually Transmitted Diseases 19
- Specimen Handling 13
- standards 77
- therapeutic use 21
- toxicity 12
- Travel 15
- Tuberculosis 30
- Vaccination 119
- Vaccination/standards 18
- Vaccines, Attenuated 16
- Vaccines, Combined 11
- Vaccines, Conjugate 12
- Vaccines, Inactivated 16
- Veterinary Medicine 16
- Young Adult 16
Name as Subject
- Acknowledgements -- Introduction -- Purpose -- Strategies for Identifying At-Risk Groups: Individual Approach -- Strategies for Identifying At-Risk Groups: Population Approach -- Integration of Data. -- Conclusion -- Glossary -- References – Notes. 1
- American Heart Association 1
- Centers for Disease Control (U.S.) 1
- Centers for Disease Control and Prevention (U.S.) 22
- Environmental Exposure 2
- FoodCORE 1
- Hydrocarbons, Chlorinated/poisoning 1
- Model Aquatic Health Code 3
- National Institutes of Health (U.S.) 1
- NIOSH Total Worker Health Program 1
- Occupational Diseases/prevention & control 3
- Trichloroethylene/toxicity 1
- Tungsten/poisoning 1
- Tungsten/toxicity 1
- United States 2
- United States. 1
- United States. Clinical Laboratory Improvement Amendments of 1988. 1
- United States. FDA Food Safety Modernization Act. 2
- United States. Food and Drug Administration. 6
- United States. Public Health Service. 4
Place as Subject
- Africa 1
- Africa, Western 1
- Americas 3
- Asia 3
- Australia 1
- California 1
- District of Columbia 3
- Europe 1
- Florida 3
- Kosovo 1
- Latin America 1
- Maryland 1
- Mexico 1
- New Jersey 3
- New York 2
- New York City, NY 1
- New Zealand 1
- Ohio 1
- Peru 1
- South America 1
- Southwestern United States 1
- Sweden 3
- United States 397
- Virginia 1
- Yugoslavia 1
Select all docs (Max 200)
801 -
801 of 801 Results
Refine Results
Refine Results:
- Diagnosis (58)
- Evaluation (6)
- Health Education (5)
- Infection Control (1)
- Infectious Disease (1)
- Other (12)
- Prevention and Control (584)
- Prevention And Control (4)
- Prevention and control (1)
- Public Health Preparedness and Response (22)
- Surveillance and Investigation (43)
- Treatment and Intervention (67)
- 2021 (3)
- 2020 (3)
- 2019 (3)
- 2018 (17)
- 2017 (13)
- 2016 (20)
- 2015 (14)
- 2014 (24)
- 2013 (34)
- 2012 (20)
- 2011 (44)
- 2010 (32)
- 2009 (34)
- 2008 (33)
- 2007 (22)
- 2006 (25)
- 2005 (23)
- 2004 (17)
- 2003 (30)
- 2002 (23)
- 2001 (30)
- 2000 (14)
- 1999 (16)
- 1998 (17)
- 1997 (14)
- 1996 (13)
- 1995 (12)
- 1994 (13)
- 1993 (17)
- 1992 (12)
- 1991 (14)
- 1990 (12)
- 1989 (16)
- 1988 (16)
- 1987 (6)
- 1986 (1)
- 1985 (3)
- 1984 (3)
- 1983 (6)
- 1981 (4)
- 1980 (1)
- 1979 (4)
- 1978 (28)
- 1977 (22)
- 1976 (29)
- 1975 (8)
- 1974 (9)
- 1973 (7)
- 1972 (7)
- Acquired Immunodeficiency Syndrome (13)
- administration & dosage (33)
- Adolescent (74)
- Adult (87)
- adverse effects (30)
- Aged (33)
- Animals (33)
- Anthrax (14)
- Anti-HIV Agents (10)
- Anti-HIV Agents/therapeutic use (11)
- Antibiotic Prophylaxis (15)
- Antiviral Agents (23)
- Bacterial Vaccines (11)
- Bioterrorism (15)
- Cardiovascular Diseases (10)
- Child (92)
- Child, Preschool (74)
- Communicable Disease Control (19)
- Communicable Disease Control/standards (10)
- Contact Tracing (11)
- contraindications (13)
- Cost-Benefit Analysis (11)
- Counseling (14)
- Cross Infection (18)
- diagnosis (13)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (10)
- Diphtheria-Tetanus-Pertussis Vaccine (12)
- Disaster Planning (16)
- Disease Outbreaks (36)
- Disease Outbreaks/prevention & control (27)
- drug therapy (15)
- Environmental Exposure (85)
- Environmental Health (14)
- epidemiology (28)
- Female (62)
- Guidelines as Topic (11)
- Health Education (10)
- Health Personnel (17)
- Health Promotion (13)
- Hepatitis B (10)
- Hepatitis B Vaccines (12)
- HIV Infections (47)
- HIV Infections/prevention & control (15)
- Humans (225)
- Immunization (16)
- Immunization, Secondary (20)
- Immunization Programs (10)
- Immunization Schedule (102)
- Industrial safety (10)
- Infant (83)
- Infant, Newborn (30)
- Infection Control (34)
- Influenza, Human (29)
- Influenza, Human/prevention & control (13)
- Influenza A virus (14)
- Influenza B virus (18)
- Influenza Vaccines (33)
- Influenza Vaccines/administration & dosage (10)
- Licensure (12)
- Male (39)
- Mass Screening (21)
- Meningococcal Infections (11)
- Meningococcal Vaccines (17)
- methods (12)
- Middle Aged (42)
- Mycobacterium tuberculosis (12)
- Occupational Diseases (21)
- Occupational Diseases/prevention & control (73)
- Occupational Exposure (47)
- Occupational Health (11)
- Patient Education as Topic (11)
- Pneumococcal Vaccines (11)
- Population Surveillance (20)
- Practice Guidelines as Topic (17)
- Pregnancy (57)
- Pregnancy Complications, Infectious (25)
- prevention & control (82)
- Public Health (14)
- Public Health Practice (18)
- Rabies (22)
- Rabies Vaccines (20)
- Randomized Controlled Trials as Topic (11)
- Risk (12)
- Risk Assessment (17)
- Risk Factors (41)
- Sexually Transmitted Diseases (19)
- Specimen Handling (13)
- standards (77)
- therapeutic use (21)
- toxicity (12)
- Travel (15)
- Tuberculosis (30)
- Vaccination (119)
- Vaccination/standards (18)
- Vaccines, Attenuated (16)
- Vaccines, Combined (11)
- Vaccines, Conjugate (12)
- Vaccines, Inactivated (16)
- Veterinary Medicine (16)
- Young Adult (16)
- Acknowledgements -- Introduction -- Purpose -- Strategies for Identifying At-Risk Groups: Individual Approach -- Strategies for Identifying At-Risk Groups: Population Approach -- Integration of Data. -- Conclusion -- Glossary -- References – Notes. (1)
- American Heart Association (1)
- Centers for Disease Control (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.) (22)
- Environmental Exposure (2)
- FoodCORE (1)
- Hydrocarbons, Chlorinated/poisoning (1)
- Model Aquatic Health Code (3)
- National Institutes of Health (U.S.) (1)
- NIOSH Total Worker Health Program (1)
- Occupational Diseases/prevention & control (3)
- Trichloroethylene/toxicity (1)
- Tungsten/poisoning (1)
- Tungsten/toxicity (1)
- United States (2)
- United States. (1)
- United States. Clinical Laboratory Improvement Amendments of 1988. (1)
- United States. FDA Food Safety Modernization Act. (2)
- United States. Food and Drug Administration. (6)
- United States. Public Health Service. (4)
- Africa (1)
- Africa, Western (1)
- Americas (3)
- Asia (3)
- Australia (1)
- California (1)
- District of Columbia (3)
- Europe (1)
- Florida (3)
- Kosovo (1)
- Latin America (1)
- Maryland (1)
- Mexico (1)
- New Jersey (3)
- New York (2)
- New York City, NY (1)
- New Zealand (1)
- Ohio (1)
- Peru (1)
- South America (1)
- Southwestern United States (1)
- Sweden (3)
- United States (397)
- Virginia (1)
- Yugoslavia (1)
- File Format:
- RIS
Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Cite
[PDF - 25.30 MB]
Personal Author:
Baker, Carol J. ;
Briere, Elizabeth Z.
...
March 22, 2013 | Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2
Description:
Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumon...
Status:
current
File Type:
[PDF - 25.30 MB]
File Type:
[PDF - 25.30 MB]
801 -
801 / 801
Refine Results:
- Diagnosis (58)
- Evaluation (6)
- Health Education (5)
- Infection Control (1)
- Infectious Disease (1)
- Other (12)
- Prevention and Control (584)
- Prevention And Control (4)
- Prevention and control (1)
- Public Health Preparedness and Response (22)
- Surveillance and Investigation (43)
- Treatment and Intervention (67)
- 2021 (3)
- 2020 (3)
- 2019 (3)
- 2018 (17)
- 2017 (13)
- 2016 (20)
- 2015 (14)
- 2014 (24)
- 2013 (34)
- 2012 (20)
- 2011 (44)
- 2010 (32)
- 2009 (34)
- 2008 (33)
- 2007 (22)
- 2006 (25)
- 2005 (23)
- 2004 (17)
- 2003 (30)
- 2002 (23)
- 2001 (30)
- 2000 (14)
- 1999 (16)
- 1998 (17)
- 1997 (14)
- 1996 (13)
- 1995 (12)
- 1994 (13)
- 1993 (17)
- 1992 (12)
- 1991 (14)
- 1990 (12)
- 1989 (16)
- 1988 (16)
- 1987 (6)
- 1986 (1)
- 1985 (3)
- 1984 (3)
- 1983 (6)
- 1981 (4)
- 1980 (1)
- 1979 (4)
- 1978 (28)
- 1977 (22)
- 1976 (29)
- 1975 (8)
- 1974 (9)
- 1973 (7)
- 1972 (7)
- Acquired Immunodeficiency Syndrome (13)
- administration & dosage (33)
- Adolescent (74)
- Adult (87)
- adverse effects (30)
- Aged (33)
- Animals (33)
- Anthrax (14)
- Anti-HIV Agents (10)
- Anti-HIV Agents/therapeutic use (11)
- Antibiotic Prophylaxis (15)
- Antiviral Agents (23)
- Bacterial Vaccines (11)
- Bioterrorism (15)
- Cardiovascular Diseases (10)
- Child (92)
- Child, Preschool (74)
- Communicable Disease Control (19)
- Communicable Disease Control/standards (10)
- Contact Tracing (11)
- contraindications (13)
- Cost-Benefit Analysis (11)
- Counseling (14)
- Cross Infection (18)
- diagnosis (13)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (10)
- Diphtheria-Tetanus-Pertussis Vaccine (12)
- Disaster Planning (16)
- Disease Outbreaks (36)
- Disease Outbreaks/prevention & control (27)
- drug therapy (15)
- Environmental Exposure (85)
- Environmental Health (14)
- epidemiology (28)
- Female (62)
- Guidelines as Topic (11)
- Health Education (10)
- Health Personnel (17)
- Health Promotion (13)
- Hepatitis B (10)
- Hepatitis B Vaccines (12)
- HIV Infections (47)
- HIV Infections/prevention & control (15)
- Humans (225)
- Immunization (16)
- Immunization, Secondary (20)
- Immunization Programs (10)
- Immunization Schedule (102)
- Industrial safety (10)
- Infant (83)
- Infant, Newborn (30)
- Infection Control (34)
- Influenza, Human (29)
- Influenza, Human/prevention & control (13)
- Influenza A virus (14)
- Influenza B virus (18)
- Influenza Vaccines (33)
- Influenza Vaccines/administration & dosage (10)
- Licensure (12)
- Male (39)
- Mass Screening (21)
- Meningococcal Infections (11)
- Meningococcal Vaccines (17)
- methods (12)
- Middle Aged (42)
- Mycobacterium tuberculosis (12)
- Occupational Diseases (21)
- Occupational Diseases/prevention & control (73)
- Occupational Exposure (47)
- Occupational Health (11)
- Patient Education as Topic (11)
- Pneumococcal Vaccines (11)
- Population Surveillance (20)
- Practice Guidelines as Topic (17)
- Pregnancy (57)
- Pregnancy Complications, Infectious (25)
- prevention & control (82)
- Public Health (14)
- Public Health Practice (18)
- Rabies (22)
- Rabies Vaccines (20)
- Randomized Controlled Trials as Topic (11)
- Risk (12)
- Risk Assessment (17)
- Risk Factors (41)
- Sexually Transmitted Diseases (19)
- Specimen Handling (13)
- standards (77)
- therapeutic use (21)
- toxicity (12)
- Travel (15)
- Tuberculosis (30)
- Vaccination (119)
- Vaccination/standards (18)
- Vaccines, Attenuated (16)
- Vaccines, Combined (11)
- Vaccines, Conjugate (12)
- Vaccines, Inactivated (16)
- Veterinary Medicine (16)
- Young Adult (16)
- Acknowledgements -- Introduction -- Purpose -- Strategies for Identifying At-Risk Groups: Individual Approach -- Strategies for Identifying At-Risk Groups: Population Approach -- Integration of Data. -- Conclusion -- Glossary -- References – Notes. (1)
- American Heart Association (1)
- Centers for Disease Control (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.) (22)
- Environmental Exposure (2)
- FoodCORE (1)
- Hydrocarbons, Chlorinated/poisoning (1)
- Model Aquatic Health Code (3)
- National Institutes of Health (U.S.) (1)
- NIOSH Total Worker Health Program (1)
- Occupational Diseases/prevention & control (3)
- Trichloroethylene/toxicity (1)
- Tungsten/poisoning (1)
- Tungsten/toxicity (1)
- United States (2)
- United States. (1)
- United States. Clinical Laboratory Improvement Amendments of 1988. (1)
- United States. FDA Food Safety Modernization Act. (2)
- United States. Food and Drug Administration. (6)
- United States. Public Health Service. (4)
- Africa (1)
- Africa, Western (1)
- Americas (3)
- Asia (3)
- Australia (1)
- California (1)
- District of Columbia (3)
- Europe (1)
- Florida (3)
- Kosovo (1)
- Latin America (1)
- Maryland (1)
- Mexico (1)
- New Jersey (3)
- New York (2)
- New York City, NY (1)
- New Zealand (1)
- Ohio (1)
- Peru (1)
- South America (1)
- Southwestern United States (1)
- Sweden (3)
- United States (397)
- Virginia (1)
- Yugoslavia (1)
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.
Have Questions?
Visit CDC InfoCall 800-232-4636
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
